2026 Antibiotics Resistance Research Grant Worldwide (PAR Foundation)

MODERATE Tx General

Strategy Notes

Strong domain alignment: the startup's drug-resistance prediction technology directly addresses antimicrobial resistance, a core focus of the grant. However, this appears research-oriented and the snippet does not clarify startup eligibility or funding amounts. Pre-seed stage and pre-incorporation status present a potential barrier.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · The 2026 call closed on 30 April 2026 — the deadline has passed (today is 9 July 2026). Two further hard blockers exist even if the call were open: (1) the grant requires institutional affiliation with a university, research institute, or equivalent non-profit able to administer grant funds — ZYCO's status as such an entity is unconfirmed; (2) the 2026 theme is strictly 'Beyond Antibiotics: Preventive Strategies That Lower the Need for Antibiotic Use,' and Eniola's CCT addiction model, IMPRINT, and GATE have no domain overlap with antimicrobial resistance prevention — only TOPOLOGIX's drug-protein interaction mapping could be tangentially reframed, but the primary body of work does not fit.